cdmo.directory
← Compare landing

Viralgen vs VVector Bio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/viralgen/vvectorbio

CategoryViralgenVVector Bio
Listed sitecdmocdmo
SummaryViralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.VVector Bio is a spin-out of McGill University developing cutting-edge technologies for cost-effective manufacturing of cell and gene therapies.
Services
  • Analytical Method Development & Validation
  • Regulatory Affairs
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
  • Translational Research
Modalities
  • AAV / Viral Vector Platform
  • Gene Therapy
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Rare Disease
  • Oncology
  • Infectious Disease
Locations
  • Headquarters & Manufacturing, San Sebastián, Basque Country, Spain
Data not yet provided.
Certifications
  • EMA · Identifier: AEMPS/EMA certified
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.